Canberra spent $10m on inaccurate antibody assessments


In March the federal government introduced it had purchased the assessments and would roll them out to GPs and hospitals inside days. They by no means arrived at clinics.

As late as final Thursday Well being Minister Greg Hunt mentioned they had been nonetheless present process evaluation.

He instructed media there was no probability the antibody kits the federal government had purchased would hit the identical issues encountered by the UK authorities – which found $US20 million ($30.9 million) of kits it had bought from China didn’t work.

“That’s as a result of we’ve been very cautious and took a preliminary pattern – we needed to make it possible for we had the choice if the science stacked up,” Mr Hunt mentioned on the time.

“The recommendation that now we have is that what Australia has bought is of the very best high quality.”

The OnSite assessments had been cleared by Australia’s medical regulator on the premise of information the corporate provided. No impartial assessments had been performed earlier than they had been authorised.

The OnSite take a look at claimed to select up 96.eight per cent of individuals with COVID-19 antibodies.

Nonetheless, impartial testing on the Doherty Institute later discovered the quantity was simply 56.9 per cent, though it rose to 84.eight per cent for folks examined 20 days after the onset of signs.

In an emailed assertion, the Well being Division defended its choice to purchase the assessments earlier than impartial testing had been performed on their efficacy. The division mentioned the assessments might nonetheless be used for population-level surveillance.

“These assessments have been demonstrated to be sufficiently correct constructive end in a affected person roughly two weeks after signs have began may very well be presumed to be constructive for COVID-19. This might then be confirmed by laboratory testing,” the assertion says.

“These assessments haven’t been bought for the aim of, and shouldn’t be used to, diagnose acute an infection of COVID‑19, as antibodies to the SARS-CoV-2 can take as much as two weeks or extra to turn out to be detectable after an infection.”

Dean Whiting, CEO of Pathology Expertise Australia, the business’s peak physique, mentioned the federal government mustn’t have purchased the assessments.


“While you have a look at all the recommendation the federal government has been given since, clearly it was the flawed name. The World Well being Organisation, the Royal School of Pathologists of Australasia, Western Australia and South Australia, they’ve all made the decision on this and mentioned these assessments can’t and shouldn’t be used for prognosis.”

The contract is the federal government’s second bungled buy of antibody testing. It additionally entered right into a contract – later cancelled – to purchase 500,000 antibody assessments from an Australian distributor of vaginal rejuvenation and erectile dysfunction machines, The Guardian has reported.

These assessments had been manufactured by Wondfo Biotech. The Chinese language biotech firm additionally provided assessments to the UK authorities, which have since turn out to be embroiled in scandal.

Wondfo denied issues with its assessments following a report by The New York Occasions that the UK authorities had concluded they didn’t work.

Signal as much as our Coronavirus Replace publication

Get our Coronavirus Replace publication for the day’s essential developments at a look, the numbers you should know and what our readers are saying. Signal as much as The Sydney Morning Herald’s publication here and The Age’s here.

Most Considered in Nationwide